Financhill
Buy
63

GTLB Quote, Financials, Valuation and Earnings

Last price:
$59.87
Seasonality move :
-21.31%
Day range:
$55.48 - $59.94
52-week range:
$40.72 - $78.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.63x
P/B ratio:
13.40x
Volume:
4.6M
Avg. volume:
3.2M
1-year change:
-3.13%
Market cap:
$9.7B
Revenue:
$579.9M
EPS (TTM):
-$0.32
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Revenue $81.2M $152.2M $252.7M $424.3M $579.9M
Revenue Growth (YoY) -- 87.35% 66.03% 67.95% 36.66%
 
Cost of Revenues $9.4M $18.5M $30M $51.7M $59.7M
Gross Profit $71.9M $133.7M $222.7M $372.7M $520.2M
Gross Profit Margin 88.46% 87.87% 88.13% 87.82% 89.7%
 
R&D Expenses $59.4M $106.6M $97.2M $156.1M $200.8M
Selling, General & Admin $140.9M $241M $254.4M $427.9M $506.8M
Other Inc / (Exp) -$4.8M $23.5M -$30.9M $21.6M -$11.8M
Operating Expenses $200.2M $347.6M $351.6M $584.1M $707.6M
Operating Income -$128.4M -$213.9M -$129M -$211.4M -$187.4M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$129.5M -$189.4M -$159.1M -$175.3M -$160.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.2M $2.8M -$1.5M $2.9M $264.1M
Net Income to Company -$130.7M -$192.2M -$157.6M -$180.7M -$428M
 
Minority Interest in Earnings -- -- $2.4M $8.4M $3.9M
Net Income to Common Excl Extra Items -$130.7M -$192.2M -$155.1M -$172.3M -$424.2M
 
Basic EPS (Cont. Ops) -$0.99 -$1.45 -$1.95 -$1.16 -$2.75
Diluted EPS (Cont. Ops) -$0.99 -$1.45 -$1.95 -$1.16 -$2.75
Weighted Average Basic Share $132.5M $132.5M $79.8M $148.4M $154.3M
Weighted Average Diluted Share $132.5M $132.5M $79.8M $148.4M $154.3M
 
EBITDA -$128.4M -$213.7M -$127.7M -$205.8M -$180.9M
EBIT -$128.4M -$213.9M -$129M -$211.4M -$187.4M
 
Revenue (Reported) $81.2M $152.2M $252.7M $424.3M $579.9M
Operating Income (Reported) -$128.4M -$213.9M -$129M -$211.4M -$187.4M
Operating Income (Adjusted) -$128.4M -$213.9M -$129M -$211.4M -$187.4M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $42.2M $66.8M $113M $149.7M $196M
Revenue Growth (YoY) -- 58.47% 69.13% 32.47% 30.99%
 
Cost of Revenues $4.6M $7.2M $14.6M $15.1M $22.1M
Gross Profit $37.5M $59.6M $98.4M $134.6M $173.9M
Gross Profit Margin 89% 89.23% 87.11% 89.92% 88.71%
 
R&D Expenses $19M $24.7M $41.1M $49.1M $61.4M
Selling, General & Admin $42.9M $67.5M $114.3M $125.8M $141.3M
Other Inc / (Exp) -$4M -$10.2M $2.7M $569K $5M
Operating Expenses $62M $92.1M $155.4M $174.9M $202.7M
Operating Income -$24.5M -$32.5M -$57M -$40.3M -$28.7M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$28.4M -$42.6M -$49.6M -$28.8M -$11.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $246K -$875K $65K $256.8M -$39.4M
Net Income to Company -- -$41.7M -$50.5M -$286.4M $28.3M
 
Minority Interest in Earnings -- $521K $2M $1.2M $1.3M
Net Income to Common Excl Extra Items -$28.6M -$41.2M -$48.5M -$285.2M $29.6M
 
Basic EPS (Cont. Ops) -$0.22 -$0.62 -$0.33 -$1.84 $0.18
Diluted EPS (Cont. Ops) -$0.22 -$0.62 -$0.33 -$1.84 $0.18
Weighted Average Basic Share $132.5M $67M $148.9M $155.1M $161.3M
Weighted Average Diluted Share $132.5M $67M $148.9M $155.1M $167.4M
 
EBITDA -$24.4M -$32.5M -$55.5M -$38.6M -$25.5M
EBIT -$24.5M -$32.5M -$57M -$40.3M -$28.7M
 
Revenue (Reported) $42.2M $66.8M $113M $149.7M $196M
Operating Income (Reported) -$24.5M -$32.5M -$57M -$40.3M -$28.7M
Operating Income (Adjusted) -$24.5M -$32.5M -$57M -$40.3M -$28.7M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue -- $221M $379.2M $539M $711.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $27M $46.6M $58M $78.3M
Gross Profit -- $194M $332.6M $481.1M $633.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $117.3M $141.1M $192.1M $229.2M
Selling, General & Admin -- $293.5M $397.2M $487.8M $562.4M
Other Inc / (Exp) $13.4M -$11.2M $13M -$1.5M -$5.9M
Operating Expenses -- $410.8M $538.3M $679.9M $791.6M
Operating Income -- -$216.9M -$205.7M -$198.8M -$158.3M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -$227.8M -$183.9M -$166.8M -$114.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $3M -$362K $262.7M -$64.4M
Net Income to Company -- -- -$185.3M -$432.6M -$51.9M
 
Minority Interest in Earnings -- $1.4M $6M $6.1M $3.3M
Net Income to Common Excl Extra Items -- -$229.4M -$179.4M -$426.4M -$48.6M
 
Basic EPS (Cont. Ops) -- -$2.02 -$1.23 -$2.78 -$0.32
Diluted EPS (Cont. Ops) -- -$2.02 -$1.23 -$2.78 -$0.32
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -$216.5M -$200.8M -$192.2M -$148.4M
EBIT -- -$216.9M -$205.7M -$198.8M -$158.3M
 
Revenue (Reported) -- $221M $379.2M $539M $711.6M
Operating Income (Reported) -- -$216.9M -$205.7M -$198.8M -$158.3M
Operating Income (Adjusted) -- -$216.9M -$205.7M -$198.8M -$158.3M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $106M $174.9M $301.4M $416.1M $547.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $12.2M $20.8M $37.4M $43.7M $62.3M
Gross Profit $93.8M $154M $264M $372.4M $485.5M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $57.9M $68.6M $112.5M $148.5M $176.8M
Selling, General & Admin $121.3M $173.8M $316.7M $376.5M $432.2M
Other Inc / (Exp) $13.4M -$21.3M $22.6M -$508K $5.5M
Operating Expenses $179.2M $242.4M $429.1M $525M $608.9M
Operating Income -$85.4M -$88.4M -$165.1M -$152.6M -$123.4M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$71M -$109.4M -$134.3M -$125.8M -$80.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.2M $1.4M $2.5M $262.3M -$66.1M
Net Income to Company -- -$110.8M -$138.6M -$390.5M -$14.3M
 
Minority Interest in Earnings -- $1.4M $5M $2.8M $2.2M
Net Income to Common Excl Extra Items -$72.2M -$109.4M -$133.6M -$387.7M -$12.1M
 
Basic EPS (Cont. Ops) -$0.54 -$1.11 -$0.91 -$2.52 -$0.09
Diluted EPS (Cont. Ops) -$0.54 -$1.11 -$0.91 -$2.52 -$0.09
Weighted Average Basic Share $397.5M $342.5M $443.3M $460.5M $479.2M
Weighted Average Diluted Share $397.5M $342.5M $443.3M $460.5M $491.9M
 
EBITDA -$85.3M -$88.1M -$161.2M -$147.6M -$115.1M
EBIT -$85.4M -$88.4M -$165.1M -$152.6M -$123.4M
 
Revenue (Reported) $106M $174.9M $301.4M $416.1M $547.8M
Operating Income (Reported) -$85.4M -$88.4M -$165.1M -$152.6M -$123.4M
Operating Income (Adjusted) -$85.4M -$88.4M -$165.1M -$152.6M -$123.4M
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Cash and Equivalents $343.3M $282.9M $884.7M $295.4M $288M
Short Term Investments -- -- $50M $641.2M $748.3M
Accounts Receivable, Net $24.8M $39.7M $77.2M $130.5M $166.7M
Inventory -- -- -- -- --
Prepaid Expenses $6.2M $6.8M $15.2M $16.2M $30M
Other Current Assets $1M $500K $265K $1.7M $1.1M
Total Current Assets $384.5M $348.5M $1.1B $1.1B $1.3B
 
Property Plant And Equipment -- -- $3.3M $6.8M $3.4M
Long-Term Investments -- -- -- $12.7M --
Goodwill -- -- $8.1M $8.1M $8.1M
Other Intangibles -- $797K $6.3M $3.9M $1.7M
Other Long-Term Assets $1.6M -- $3.4M $321K $559K
Total Assets $391.8M $362.6M $1.1B $1.2B $1.3B
 
Accounts Payable $1.7M $3.1M $5M $5.2M $1.7M
Accrued Expenses $4.2M $4M $11.6M $19.5M $28M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- $716K $410K
Other Current Liabilities $559K $1.2M -- $2.5M --
Total Current Liabilities $77.8M $127.2M $241.6M $306.3M $662.1M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $526.6M $593.8M $292.2M $344.5M $699.9M
 
Common Stock -- -- -- -- --
Other Common Equity Adj $4.1M -$19.9M $7.7M -$705K $2.3M
Common Equity -$134.7M -$231.2M $774.9M $771M $571.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $24.4M $53.7M $46.8M
Total Equity -$134.7M -$231.2M $799.3M $824.7M $617.9M
 
Total Liabilities and Equity $391.8M $362.6M $1.1B $1.2B $1.3B
Cash and Short Terms $343.3M $282.9M $934.7M $936.7M $1B
Total Debt -- -- -- -- --
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Cash and Equivalents -- $824.7M $372.2M $285.3M $176.6M
Short Term Investments -- $100M $555.6M $704.3M $740.3M
Accounts Receivable, Net -- $57M $97.6M $135.6M $197.6M
Inventory -- -- -- -- --
Prepaid Expenses -- $9.8M $15.7M $21.4M --
Other Current Assets -- $970K $819K $1.2M $43.1M
Total Current Assets -- $1B $1.1B $1.2B $1.2B
 
Property Plant And Equipment -- -- $5.6M $4.2M $4M
Long-Term Investments -- -- $13.6M $9.6M --
Goodwill -- -- $8.1M $8.1M $16.1M
Other Intangibles -- -- $4.5M $2.3M $19.5M
Other Long-Term Assets -- $4.5M $759K $59K $3.6M
Total Assets -- $1B $1.1B $1.2B $1.3B
 
Accounts Payable -- $4.9M $6.2M $5M $2.2M
Accrued Expenses -- $6.9M $13.5M $10.9M $18.2M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- $522K $256K
Other Current Liabilities -- $815K $53K -- $641K
Total Current Liabilities -- $178.9M $264.5M $585.9M $464.5M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- $219.4M $305.6M $633.7M $482.4M
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -$758K -$2.9M $1.5M -$5M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $25M $51.1M $46.6M $45.5M
Total Equity -- $809.4M $814.7M $593.2M $770.2M
 
Total Liabilities and Equity -- $1B $1.1B $1.2B $1.3B
Cash and Short Terms -- $924.7M $927.8M $989.6M $917M
Total Debt -- -- -- -- --
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Net Income to Stockholders -$130.7M -$192.2M -$157.6M -$180.7M -$428M
Depreciation & Amoritzation -- $222K $1.2M $5.6M $6.5M
Stock-Based Compensation $40.9M $111.8M $30M $122.6M $163M
Change in Accounts Receivable -$13.5M -$14.7M -$38.2M -$54.2M -$36.3M
Change in Inventories -- -- -- -- --
Cash From Operations -$60.2M -$73.6M -$49.8M -$77.4M $35M
 
Capital Expenditures -- -- $3.5M $6.1M $1.6M
Cash Acquisitions -- -- -$323K -$9.6M --
Cash From Investing -- -$842K -$53.9M -$605.7M -$86.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -$820K -$590K -- --
Other Financing Activities -- -- $21.8M $58.6M --
Cash From Financing $271.3M $12.9M $701.2M $97.5M $45.2M
 
Beginning Cash (CF) $132.5M $343.3M $282.9M $887.2M $297.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $211.1M -$61.5M $597.5M -$585.6M -$6M
Ending Cash (CF) $343.3M $282.9M $887.2M $297.9M $288M
 
Levered Free Cash Flow -$60.2M -$73.6M -$53.4M -$83.5M $33.4M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders -- -$41.7M -$50.5M -$286.4M $28.3M
Depreciation & Amoritzation -- $82K $1.5M $1.6M $3.2M
Stock-Based Compensation -- $8.6M $33.7M $41.3M $48M
Change in Accounts Receivable -- -$10.3M -$8.6M -$30.6M -$32.9M
Change in Inventories -- -- -- -- --
Cash From Operations -- -$10.1M -$1.2M -$6M -$177M
 
Capital Expenditures -- -- $1.8M $736K $1.1M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$50M -$40.4M $14.6M -$92.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$2.6M $916K -- -$4.9M
Cash From Financing -- $658.9M $7.1M $4.7M $2.9M
 
Beginning Cash (CF) -- $226.3M $413.3M $273.2M $438.6M
Foreign Exchange Rate Adjustment -- -$331K -$4M -$1.2M $4.9M
Additions / Reductions -- $598.8M -$34.5M $13.3M -$266.9M
Ending Cash (CF) -- $824.7M $374.7M $285.3M $176.6M
 
Levered Free Cash Flow -- -$10.1M -$3M -$6.7M -$178.1M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders -- -- -$185.3M -$432.6M -$51.9M
Depreciation & Amoritzation -- -- $4.9M $6.6M $9.9M
Stock-Based Compensation -- $17.2M $101.7M $153.7M $182.3M
Change in Accounts Receivable -- -- -$43M -$37.3M -$62.7M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -$66.8M -$1.5M -$102.3M
 
Capital Expenditures -- -- $5M $2.3M $2.9M
Cash Acquisitions -- -- -$9.9M -- -$20.2M
Cash From Investing -- -- -$477.8M -$132.3M -$44.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- $57.3M -- --
Cash From Financing -- -- $95.2M $42.1M $35.9M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -$449.3M -$91.7M -$110.7M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -$66.8M -$3.9M -$105.3M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders -- -$110.8M -$138.6M -$390.5M -$14.3M
Depreciation & Amoritzation -- $251K $4M $5M $8.3M
Stock-Based Compensation -- $17.2M $88.9M $120M $139.3M
Change in Accounts Receivable -- -$17.4M -$22.2M -$5.3M -$31.7M
Change in Inventories -- -- -- -- --
Cash From Operations -- -$48.7M -$65.7M $10.2M -$127.2M
 
Capital Expenditures -- -- $5M $1.3M $2.6M
Cash Acquisitions -- -- -$9.6M -- -$20.2M
Cash From Investing -- -$100M -$523.9M -$50.5M -$8.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -$590K -- -- --
Other Financing Activities -- $23.1M $58.6M -- -$4.9M
Cash From Financing -- $691.6M $85.6M $30.2M $20.9M
 
Beginning Cash (CF) -- $781.3M $2.2B $889.6M $1.1B
Foreign Exchange Rate Adjustment -- -$973K -$8.5M -$2.6M $3.5M
Additions / Reductions -- $542.8M -$504M -$10M -$114.8M
Ending Cash (CF) -- $1.3B $1.7B $877M $1B
 
Levered Free Cash Flow -- -$48.7M -$70.7M $8.9M -$129.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock